Elli Schwartz
ellischwartz.bsky.social
Elli Schwartz
@ellischwartz.bsky.social
MD-PhD student at the University of Minnesota
Reposted by Elli Schwartz
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care.

✅ Just Accepted
#IDSky
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care
People with advanced HIV disease (CD4 ≤200 cells/µL) remain at high risk for opportunistic infections, hospitalization, and death, despite access to antiretroviral therapy (ART). We evaluated serum C-reactive protein (CRP) as a predictor of 30-day hospitalization or death among...
bit.ly
October 9, 2025 at 8:55 PM
Reposted by Elli Schwartz
High CRP = high risk.
In a Ugandan cohort of 1,378 people with advanced HIV (CD4 ≤200), Dr. Boulware’s team found that CRP ≥10 mg/L predicted a 4× higher risk of hospitalization and 10× higher risk of death within 30 days. #IDSky
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of care
Among Ugandan outpatients with advanced HIV, elevated serum CRP (≥10 mg/L) predicted 30-day risk of opportunistic infection, hospitalization, and death. Ea
academic.oup.com
October 11, 2025 at 2:52 PM
Reposted by Elli Schwartz
Dr. Radha Rajasingham & Dr. Nathan Bahr explore this critical question in a new article. Their work highlights ongoing knowledge gaps around ART timing, antifungal regimens, and how to ensure treatments are effective, safe, and accessible worldwide. 🌍💊
www.tandfonline.com/doi/full/10....
Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis?
Published in Expert Review of Anti-infective Therapy (Just accepted, 2025)
www.tandfonline.com
October 3, 2025 at 11:56 AM